Related Experiment Video
Updated: Jun 19, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Pre- and Post-Sexual Maturity Liver-specific ERα Knockout Does Not Impact Hepatic Mitochondrial Function
Kelly N Z Fuller1,2, Julie Allen1,2, Roshan Kumari1,2
1Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Female mice are protected against fatty liver disease, but the role of estrogen receptor alpha (ERα) is unclear. This study found that removing ERα in female livers did not affect protection against fatty liver or alter mitochondrial function, suggesting ERα is not essential for these protective effects.
Area of Science:
- Endocrinology
- Hepatology
- Mitochondrial Biology
Background:
- Premenopausal women and female rodents exhibit protection against hepatic steatosis compared to males.
- Estrogen action is implicated in this protective mechanism, but the specific pathways remain largely unknown.
- Liver estrogen receptor alpha (ERα) is a key mediator of estrogen signaling in the liver.
Purpose of the Study:
- To investigate the role of liver ERα in protection against high-fat diet (HFD)-induced hepatic steatosis in female mice.
- To determine if ERα mediates sexual dimorphism in hepatic mitochondrial function.
- To assess the impact of developmental timing of ERα reduction on HFD outcomes.
Main Methods:
- Validation of an inducible mouse model with liver-specific reduction of ERα (LERKO) using adeno-associated virus (AAV) Cre.
- Phenotyping liver health and mitochondrial function (respiration, H2O2 emission, OXPHOS proteins) in LERKO mice fed a HFD.
- Comparison of outcomes based on timing of LERKO induction (pre- vs. post-sexual maturity).
Main Results:
- No significant differences in body weight, body composition, or hepatic steatosis were observed between LERKO and control mice on HFD.
- Hepatic mitochondrial oxygen consumption, hydrogen peroxide emission, coupling, and OXPHOS protein levels were not altered by LERKO genotype or induction timing.
- Transcriptomic analysis revealed that developmental stage significantly influenced hepatic gene expression in LERKO mice.
Conclusions:
- Hepatic ERα is not required for the protection against HFD-induced hepatic steatosis observed in female mice.
- ERα does not appear to mediate the sexual dimorphism in hepatic mitochondrial function.
- Developmental timing influences hepatic gene expression, but ERα's role in HFD response is minimal in females.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

